Ewa M Slominska Selected Research

N-methylnicotinamide

4/2018	Cardioprotective effect of N-methylnicotinamide salt of pyruvate in experimental model of cardiac hypoxia.
1/2018	Nicotinamide metabolism alterations in bladder cancer: Preliminary studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ewa M Slominska Research Topics

Disease

8	Inflammation (Inflammations) 10/2020 - 08/2015
7	Chronic Kidney Failure (Chronic Renal Failure) 01/2011 - 02/2002
6	Thrombosis (Thrombus) 10/2020 - 08/2015
5	Atherosclerosis 01/2019 - 01/2014
4	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2018
4	Aortic Valve Disease 06/2021 - 12/2016
3	Neoplasms (Cancer) 05/2022 - 01/2018
3	Huntington Disease (Huntington's Disease) 06/2021 - 12/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 04/2018
2	Hyperlipidemias (Hyperlipidemia) 02/2020 - 01/2018
2	Ischemia 04/2018 - 01/2014
2	Melanoma (Melanoma, Malignant) 01/2018 - 09/2005
2	Renal Insufficiency (Renal Failure) 01/2011 - 07/2004
1	Insulin Resistance 11/2021
1	Dyslipidemias (Dyslipidemia) 11/2021
1	Triple Negative Breast Neoplasms 04/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 02/2020
1	Hypertension (High Blood Pressure) 02/2020
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Hypoxia (Hypoxemia) 04/2018
1	Hypernatremia 04/2018
1	Myocardial Infarction 04/2018
1	Hypercholesterolemia 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Glioma (Gliomas) 01/2018
1	Hyperglycemia 01/2018
1	Pathologic Processes 01/2018
1	Vascular System Injuries 01/2018
1	Acute-Phase Reaction 09/2015
1	Hepatitis 09/2015
1	Heart Diseases (Heart Disease) 01/2014

Drug/Important Bio-Agent (IBA)

11	NucleotidesIBA 05/2022 - 10/2006
11	Adenosine (Adenocard)FDA LinkGeneric 04/2021 - 01/2014
7	EnzymesIBA 06/2021 - 01/2011
7	Adenosine Triphosphate (ATP)IBA 02/2020 - 06/2002
6	Adenosine DeaminaseIBA 04/2021 - 11/2016
5	NAD (NADH)IBA 01/2018 - 06/2006
4	Apolipoproteins E (ApoE)IBA 11/2021 - 11/2016
3	Adenine NucleotidesIBA 06/2021 - 11/2016
3	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2019 - 01/2011
3	N-methyl-2-pyridone-5-carboxamideIBA 01/2018 - 02/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2021 - 01/2018
2	LipidsIBA 11/2021 - 01/2019
2	Adenosine Monophosphate (AMP)IBA 02/2020 - 08/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2018
2	N(1)-methylnicotinamideIBA 01/2019 - 09/2015
2	Pentostatin (Nipent)FDA LinkGeneric 12/2018 - 11/2016
2	N-methylnicotinamideIBA 04/2018 - 01/2018
2	Adenosine Diphosphate (ADP)IBA 01/2018 - 09/2015
2	Adenine FDA LinkGeneric 11/2016 - 06/2002
1	LDL Receptors (LDL Receptor)IBA 11/2021
1	ApolipoproteinsIBA 11/2021
1	polyglutamineIBA 06/2021
1	Proteins (Proteins, Gene)FDA Link 06/2021
1	Purine NucleotidesIBA 06/2021
1	Hormones (Hormone)IBA 04/2021
1	Triglycerides (Triacylglycerol)IBA 02/2020
1	Purinergic AgentsIBA 02/2020
1	LDL CholesterolIBA 02/2020
1	CholesterolIBA 02/2020
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2019
1	Amino Acids FDA Link 01/2019
1	Arginine (L-Arginine)FDA Link 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2018
1	Pyruvic Acid (Pyruvate)IBA 04/2018
1	SodiumIBA 04/2018
1	SaltsIBA 04/2018
1	pyridineIBA 01/2018
1	alpha,beta-methyleneadenosine 5'-diphosphateIBA 01/2018
1	FlavonoidsIBA 01/2018
1	Uric Acid (Urate)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Inosine FDA Link 11/2016
1	Dihydrotachysterol (AT 10)IBA 11/2016
1	HaptoglobinsIBA 09/2015
1	CytokinesIBA 09/2015
1	Concanavalin AIBA 09/2015
1	Alanine (L-Alanine)FDA Link 09/2015
1	Interleukin-6 (Interleukin 6)IBA 09/2015
1	Adrenergic Agents (Adrenergic Drugs)IBA 08/2015
1	AMP Deaminase (Myoadenylate Deaminase)IBA 01/2014
1	IMP DehydrogenaseIBA 01/2011
1	tiazofurinIBA 01/2011
1	4-pyridoneIBA 01/2011
1	3-(1-deoxyribofuranosyl)benzamideIBA 01/2011
1	nicotinamide-beta-ribosideIBA 01/2011
1	triphosphoric acid (triphosphate)IBA 01/2011
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2006
1	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 09/2005

Therapy/Procedure

3	Therapeutics 06/2021 - 11/2016
2	Kidney Transplantation 07/2004 - 02/2002
1	Radiotherapy 02/2020
1	Induction Chemotherapy 02/2020
1	Intravenous Injections 01/2018
1	Prostheses and Implants (Prosthesis) 04/2016
1	Heterologous Transplantation (Xenotransplantation) 08/2015